Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases

J Dermatolog Treat. 2009;20(1):61-2. doi: 10.1080/09546630802206652.

Abstract

Efalizumab-associated papular psoriasis is a common adverse event caused by efelizumab therapy. This clinical manifestation is characterized by a transient popular eruption localized especially on the flexural areas and on the back. We report three cases of efalizumab-associated papular psoriasis.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Axilla
  • Biopsy, Needle
  • Dose-Response Relationship, Drug
  • Drug Eruptions / drug therapy
  • Drug Eruptions / etiology
  • Drug Eruptions / pathology
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Psoriasis / chemically induced*
  • Psoriasis / drug therapy
  • Psoriasis / pathology*
  • Risk Assessment
  • Sampling Studies

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • efalizumab